An Australian stem cell and regenerative medicine company

December 16, 2024

Euroz Hartleys update: "Phase 1 DFU Success; Funding Secured"

View Report

November 06, 2024

Euroz Hartleys intitiates coverage: "Unlimited Cells, Unlimited Possibilities"

View Report

August 06, 2024

MST Access update: "Clinical Trials On Track"

View Report

May 10, 2024

MST Access update: "3Q24: progressing on all fronts"

View Report

February 28, 2024

MST Access update: "Phase 1 DFU trial: initial data very promising; recruitment continues"

View Report

View the MST Access Research Update on Cynata Therapeutics